Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
According to our market capitalization data, Eli Lilly (LLY) reached a market cap of $679.94 billion, securing the top spot among global Pharmaceuticals companies. Johnson & Johnson (JNJ) and AbbVie (ABBV) follow closely behind. The data was last updated on April 16, 2025.
| Rank | Name | Market Cap | Price | MCap(30D) | MCap(1Y) | Country |
|---|---|---|---|---|---|---|
|
201
|
 Centessa Pharmaceuticals
CNTA
|
$1.59 B | $11.94 |
0.00%
|
49.4%
|
United Kingdom
|
|
202
|
 Galapagos NV
GLPG
|
$1.57 B | $23.88 |
0.00%
|
-12.9%
|
Belgium
|
|
203
|
 Arcutis Biotherapeutics
ARQT
|
$1.56 B | $13.19 |
0.00%
|
13.1%
|
United States
|
|
204
|
 BioCryst Pharmaceuticals
BCRX
|
$1.55 B | $7.40 |
0.00%
|
88.4%
|
United States
|
|
205
|
 Kiniksa Pharmaceuticals
KNSA
|
$1.54 B | $21.22 |
0.00%
|
16.5%
|
|
|
206
|
 CG Oncology
CGON
|
$1.53 B | $20.11 |
0.00%
|
-22.4%
|
United States
|
|
207
|
 ANI Pharmaceuticals
ANIP
|
$1.50 B | $69.55 |
0.00%
|
-9.0%
|
United States
|
|
208
|
 Pharma Mar
PHM.MC
|
$1.49 B | $86.30 |
0.00%
|
285.2%
|
Spain
|
|
209
|
 IDEAYA Biosciences
IDYA
|
$1.49 B | $16.98 |
0.00%
|
-44.2%
|
United States
|
|
210
|
 ARS Pharmaceuticals
SPRY
|
$1.47 B | $14.99 |
0.00%
|
29.6%
|
United States
|
|
211
|
 Disc Medicine
IRON
|
$1.43 B | $41.31 |
0.00%
|
80.7%
|
United States
|
|
212
|
 Sumitomo Pharma
4506.T
|
$1.42 B | $3.57 |
0.00%
|
42.6%
|
Japan
|
|
213
|
 Dynavax Technologies
DVAX
|
$1.42 B | $11.41 |
0.00%
|
15.5%
|
United States
|
|
214
|
 MannKind Corp
MNKD
|
$1.41 B | $4.64 |
0.00%
|
36.3%
|
United States
|
|
215
|
 Vera Therapeutics
VERA
|
$1.38 B | $21.59 |
0.00%
|
-10.3%
|
United States
|
|
216
|
 Mesoblast
MESO
|
$1.37 B | $10.77 |
0.00%
|
257.3%
|
Australia
|
|
217
|
 Immunocore
IMCR
|
$1.35 B | $27.31 |
0.00%
|
-47.7%
|
United Kingdom
|
|
218
|
 Faes Farma
FAE.MC
|
$1.34 B | $4.30 |
0.00%
|
22.5%
|
Spain
|
|
219
|
 Hanmi Pharmaceutical
008930.KS
|
$1.32 B | $19.55 |
0.00%
|
-9.2%
|
South Korea
|
|
220
|
 Travere Therapeutics
TVTX
|
$1.32 B | $14.91 |
0.00%
|
252.3%
|
United States
|
|
221
|
 Granules India
GRANULES.NS
|
$1.30 B | $5.36 |
0.00%
|
41.2%
|
India
|
|
222
|
 Celldex Therapeutics
CLDX
|
$1.22 B | $18.37 |
0.00%
|
-45.7%
|
United States
|
|
223
|
 Ocular Therapeutix
OCUL
|
$1.20 B | $7.53 |
0.00%
|
-2.5%
|
United States
|
|
224
|
 Evotec
EVO
|
$1.20 B | $3.37 |
0.00%
|
-36.7%
|
Germany
|
|
225
|
 Liquidia Technologies
LQDA
|
$1.16 B | $13.60 |
0.00%
|
17.0%
|
United States
|
|
226
|
 Adaptive Biotechnologies
ADPT
|
$1.15 B | $7.74 |
0.00%
|
214.8%
|
United States
|
|
227
|
 Innoviva
INVA
|
$1.14 B | $18.11 |
0.00%
|
25.7%
|
United States
|
|
228
|
 Indivior PLC
INDV
|
$1.14 B | $9.11 |
0.00%
|
-50.5%
|
United States
|
|
229
|
 Marksans Pharma
MARKSANS.NS
|
$1.13 B | $2.50 |
0.00%
|
51.6%
|
India
|
|
230
|
 Genomma Lab Internacional SAB de CV
LABB.MX
|
$1.12 B | $1.12 |
0.00%
|
106.0%
|
Mexico
|
|
231
|
 Amphastar Pharmaceuticals
AMPH
|
$1.12 B | $23.50 |
0.00%
|
-19.6%
|
United States
|
|
232
|
 Ardelyx
ARDX
|
$1.11 B | $4.64 |
0.00%
|
-15.0%
|
United States
|
|
233
|
 Calliditas Therapeutics
CALT
|
$1.10 B | $40.00 |
0.00%
|
113.4%
|
Sweden
|
|
234
|
 Structure Therapeutics
GPCR
|
$1.08 B | $18.90 |
0.00%
|
-34.5%
|
United States
|
|
235
|
 Aurinia Pharmaceuticals
AUPH
|
$1.06 B | $7.75 |
0.00%
|
58.7%
|
Canada
|
|
236
|
 Iovance Biotherapeutics
IOVA
|
$1.06 B | $3.23 |
0.00%
|
-54.9%
|
United States
|
|
237
|
 Viridian Therapeutics
VRDN
|
$1.04 B | $12.80 |
0.00%
|
19.2%
|
United States
|
|
238
|
 Vetoquinol
VETO.PA
|
$1.03 B | $87.15 |
0.00%
|
-22.9%
|
France
|
|
239
|
 Novavax
NVAX
|
$1.03 B | $6.39 |
0.00%
|
110.5%
|
United States
|
|
240
|
 Syndax Pharmaceuticals
SNDX
|
$0.97 B | $11.33 |
0.00%
|
-27.0%
|
United States
|
|
241
|
 Cosmo Pharmaceuticals
C43.F
|
$0.96 B | $58.78 |
0.00%
|
-2.2%
|
Ireland
|
|
242
|
 Wave Life Sciences
WVE
|
$0.96 B | $6.28 |
0.00%
|
125.7%
|
Singapore
|
|
243
|
 Poseida Therapeutics
PSTX
|
$0.93 B | $9.50 |
0.00%
|
365.7%
|
United States
|
|
244
|
 Gubra A/S
GUBRA.CO
|
$0.92 B | $56.30 |
0.00%
|
119.1%
|
Denmark
|
|
245
|
 Mineralys Therapeutics
MLYS
|
$0.90 B | $13.88 |
0.00%
|
-20.7%
|
United States
|
|
246
|
 Dyne Therapeutics
DYN
|
$0.89 B | $7.85 |
0.00%
|
-41.7%
|
United States
|
|
247
|
 89bio
ETNB
|
$0.88 B | $6.05 |
0.00%
|
19.9%
|
United States
|
|
248
|
 Collegium Pharmaceutical
COLL
|
$0.87 B | $27.12 |
0.00%
|
-13.9%
|
United States
|
|
249
|
 Oculis Holding AG
OCS
|
$0.86 B | $17.93 |
0.00%
|
81.4%
|
Switzerland
|
|
250
|
 Harrow Health
HROW
|
$0.85 B | $23.79 |
0.00%
|
170.7%
|
United States
|
|
251
|
 Enliven Therapeutics
ELVN
|
$0.84 B | $17.05 |
0.00%
|
24.6%
|
United States
|
|
252
|
 FDC India
FDC.NS
|
$0.81 B | $4.95 |
0.00%
|
7.5%
|
India
|
|
253
|
 Chimerix
CMRX
|
$0.80 B | $8.55 |
0.00%
|
351.1%
|
United States
|
|
254
|
 Avid Bioservices
CDMO
|
$0.80 B | $12.49 |
0.00%
|
86.1%
|
United States
|
|
255
|
 Geron
GERN
|
$0.80 B | $1.25 |
0.00%
|
-23.4%
|
United States
|
|
256
|
 Gyre Therapeutics
GYRE
|
$0.79 B | $8.40 |
0.00%
|
-24.8%
|
United States
|
|
257
|
 SPIMACO (Saudi Pharmaceutical Industries and Medical Appliances Corporation)
2070.SR
|
$0.78 B | $6.54 |
0.00%
|
-12.1%
|
Saudi Arabia
|
|
258
|
 Anavex Life Sciences
AVXL
|
$0.78 B | $9.12 |
0.00%
|
116.5%
|
United States
|
|
259
|
 Spyre Therapeutics
SYRE
|
$0.77 B | $12.71 |
0.00%
|
-33.7%
|
United States
|
|
260
|
 Avadel Pharmaceuticals
AVDL
|
$0.76 B | $7.91 |
0.00%
|
-52.1%
|
Ireland
|
|
261
|
 Intellia Therapeutics
NTLA
|
$0.76 B | $7.36 |
0.00%
|
-55.4%
|
United States
|
|
262
|
 Zymeworks
ZYME
|
$0.76 B | $10.94 |
0.00%
|
69.6%
|
Canada
|
|
263
|
 Pharvaris
PHVS
|
$0.76 B | $13.94 |
0.00%
|
-18.5%
|
Netherlands
|
|
264
|
 Nurix Therapeutics
NRIX
|
$0.75 B | $9.82 |
0.00%
|
27.9%
|
United States
|
|
265
|
 Day One Biopharmaceuticals
DAWN
|
$0.73 B | $7.19 |
0.00%
|
-20.1%
|
United States
|
|
266
|
 Curevac
CVAC
|
$0.73 B | $3.23 |
0.00%
|
42.0%
|
Germany
|
|
267
|
 AbCellera
ABCL
|
$0.72 B | $2.43 |
0.00%
|
-16.6%
|
Canada
|
|
268
|
 Rocket Pharmaceuticals
RCKT
|
$0.70 B | $6.53 |
0.00%
|
-57.3%
|
United States
|
|
269
|
 Strides Pharma
STAR.NS
|
$0.69 B | $7.48 |
0.00%
|
-26.0%
|
India
|
|
270
|
 Nuvation Bio
NUVB
|
$0.69 B | $2.02 |
0.00%
|
-15.2%
|
United States
|
|
271
|
 Xeris Pharmaceuticals
XERS
|
$0.67 B | $4.38 |
0.00%
|
100.6%
|
United States
|
|
272
|
 Xencor
XNCR
|
$0.67 B | $9.54 |
0.00%
|
-11.7%
|
United States
|
|
273
|
 LENZ Therapeutics
LENZ
|
$0.66 B | $23.89 |
0.00%
|
41.2%
|
United States
|
|
274
|
 Hikal
HIKAL.NS
|
$0.65 B | $5.31 |
0.00%
|
20.4%
|
India
|
|
275
|
 Evolus
EOLS
|
$0.65 B | $10.23 |
0.00%
|
12.6%
|
United States
|
|
276
|
 Immunome
IMNM
|
$0.64 B | $7.40 |
0.00%
|
-35.4%
|
United States
|
|
277
|
 ArriVent BioPharma
AVBP
|
$0.63 B | $18.63 |
0.00%
|
67.8%
|
United States
|
|
278
|
 Exscientia
EXAI
|
$0.63 B | $4.84 |
0.00%
|
12.0%
|
United Kingdom
|
|
279
|
 PolyPeptide Group
PPGN.SW
|
$0.62 B | $18.80 |
0.00%
|
-19.8%
|
Switzerland
|
|
280
|
 ChromaDex
CDXC
|
$0.61 B | $7.52 |
0.00%
|
41.1%
|
United States
|
|
281
|
 Arbutus Biopharma
ABUS
|
$0.61 B | $3.16 |
0.00%
|
19.8%
|
United States
|
|
282
|
 Trevi Therapeutics
TRVI
|
$0.60 B | $6.20 |
0.00%
|
57.4%
|
United States
|
|
283
|
 Praxis Precision Medicines
PRAX
|
$0.60 B | $29.67 |
0.00%
|
67.1%
|
United States
|
|
284
|
 KalVista Pharmaceuticals
KALV
|
$0.60 B | $12.02 |
0.00%
|
-21.1%
|
United States
|
|
285
|
 Replimune
REPL
|
$0.59 B | $7.71 |
0.00%
|
82.0%
|
United States
|
|
286
|
 KYORIN Pharmaceutical
4569.T
|
$0.58 B | $10.06 |
0.00%
|
-17.8%
|
Japan
|
|
287
|
 SPARC
SPARC.NS
|
$0.57 B | $1.76 |
0.00%
|
-48.6%
|
India
|
|
288
|
 Valneva SE
VALN
|
$0.57 B | $7.05 |
0.00%
|
-41.4%
|
France
|
|
289
|
 Pharming Group
PHAR
|
$0.56 B | $8.16 |
0.00%
|
-9.5%
|
Netherlands
|
|
290
|
 GH Research
GHRS
|
$0.56 B | $8.99 |
0.00%
|
30.2%
|
Ireland
|
|
291
|
 AnaptysBio
ANAB
|
$0.56 B | $18.10 |
0.00%
|
-39.5%
|
United States
|
|
292
|
 Cogent Biosciences
COGT
|
$0.55 B | $4.87 |
0.00%
|
34.2%
|
United States
|
|
293
|
 Bicycle Therapeutics
BCYC
|
$0.54 B | $7.79 |
0.00%
|
-32.1%
|
United Kingdom
|
|
294
|
 Immatics
IMTX
|
$0.53 B | $4.37 |
0.00%
|
-50.6%
|
Germany
|
|
295
|
 Keros Therapeutics
KROS
|
$0.53 B | $13.09 |
0.00%
|
-82.3%
|
United States
|
|
296
|
 Opthea
OPT
|
$0.52 B | $3.41 |
0.00%
|
53.2%
|
Australia
|
|
297
|
 uniQure
QURE
|
$0.52 B | $9.65 |
0.00%
|
203.6%
|
Netherlands
|
|
298
|
 Arvinas
ARVN
|
$0.52 B | $7.58 |
0.00%
|
-43.3%
|
United States
|
|
299
|
 Prothena
PRTA
|
$0.52 B | $9.59 |
0.00%
|
-32.5%
|
Ireland
|
|
300
|
 Savara Pharmaceuticals
SVRA
|
$0.51 B | $2.93 |
0.00%
|
-43.8%
|
United States
|
|
301
|
 UroGen Pharma
URGN
|
$0.50 B | $10.75 |
0.00%
|
-24.6%
|
United States
|
|
302
|
 Akebia Therapeutics
AKBA
|
$0.49 B | $1.89 |
0.00%
|
51.1%
|
United States
|
|
303
|
 Kura Oncology
KURA
|
$0.49 B | $6.03 |
0.00%
|
-51.1%
|
United States
|
|
304
|
 Cormedix
CRMD
|
$0.48 B | $7.40 |
0.00%
|
89.2%
|
United States
|
|
305
|
 Boiron
BOI.PA
|
$0.48 B | $27.52 |
0.00%
|
-17.4%
|
France
|
|
306
|
 Ginkgo Bioworks
DNA
|
$0.48 B | $8.25 |
0.00%
|
-61.2%
|
United States
|
|
307
|
 Tilray
TLRY
|
$0.47 B | $0.47 |
0.00%
|
-45.9%
|
Canada
|
|
308
|
 Relay Therapeutics
RLAY
|
$0.47 B | $2.76 |
0.00%
|
-35.4%
|
United States
|
|
309
|
 Sage Therapeutics
SAGE
|
$0.46 B | $7.54 |
0.00%
|
-42.2%
|
United States
|
|
310
|
 Tyra Biosciences
TYRA
|
$0.46 B | $8.66 |
0.00%
|
-14.3%
|
United States
|
|
311
|
 Cullinan Therapeutics
CGEM
|
$0.46 B | $7.80 |
0.00%
|
-43.5%
|
United States
|
|
312
|
 Capricor Therapeutics
CAPR
|
$0.45 B | $9.82 |
0.00%
|
151.2%
|
United States
|
|
313
|
 Verve Therapeutics
VERV
|
$0.44 B | $4.97 |
0.00%
|
18.4%
|
United States
|
|
314
|
 Maravai LifeSciences
MRVI
|
$0.44 B | $1.73 |
0.00%
|
-44.4%
|
United States
|
|
315
|
 Theravance Biopharma
TBPH
|
$0.43 B | $8.63 |
0.00%
|
0.95%
|
|
|
316
|
 SIGA Technologies
SIGA
|
$0.43 B | $6.04 |
0.00%
|
-28.7%
|
United States
|
|
317
|
 MeiraGTx
MGTX
|
$0.43 B | $5.45 |
0.00%
|
27.0%
|
United States
|
|
318
|
 RPG Life Sciences
RPGLIFE.NS
|
$0.43 B | $25.77 |
0.00%
|
37.5%
|
India
|
|
319
|
 Precigen
PGEN
|
$0.42 B | $1.44 |
0.00%
|
35.9%
|
United States
|
|
320
|
 Mind Medicine
MNMD
|
$0.42 B | $5.60 |
0.00%
|
-14.2%
|
United States
|
|
321
|
 Regencell Bioscience
RGC
|
$0.42 B | $32.28 |
0.00%
|
-20.9%
|
Hong Kong
|
|
322
|
 Stoke Therapeutics
STOK
|
$0.42 B | $7.75 |
0.00%
|
-12.4%
|
United States
|
|
323
|
 Sequent Scientific
SEQUENT.NS
|
$0.41 B | $1.66 |
0.00%
|
49.9%
|
India
|
|
324
|
 PureTech Health
PRTC
|
$0.40 B | $16.68 |
0.00%
|
-31.9%
|
United States
|
|
325
|
 Omeros Corporation
OMER
|
$0.40 B | $6.87 |
0.00%
|
158.7%
|
United States
|
|
326
|
 Absci
ABSI
|
$0.40 B | $3.12 |
0.00%
|
-18.1%
|
United States
|
|
327
|
 EyePoint Pharmaceuticals
EYPT
|
$0.39 B | $5.67 |
0.00%
|
-70.1%
|
United States
|
|
328
|
 Abivax
ABVX
|
$0.38 B | $6.06 |
0.00%
|
-57.1%
|
France
|
|
329
|
 Tourmaline Bio
TRML
|
$0.38 B | $14.93 |
0.00%
|
-16.5%
|
United States
|
|
330
|
 Sana Biotechnology
SANA
|
$0.38 B | $1.70 |
0.00%
|
-66.9%
|
United States
|
|
331
|
 Revance Therapeutics
RVNC
|
$0.38 B | $3.65 |
0.00%
|
-2.9%
|
United States
|
|
332
|
 Aarti Drugs
AARTIDRUGS.NS
|
$0.38 B | $4.15 |
0.00%
|
-14.7%
|
India
|
|
333
|
 G1 Therapeutics
GTHX
|
$0.38 B | $7.15 |
0.00%
|
67.1%
|
United States
|
|
334
|
 Zevra Therapeutics
ZVRA
|
$0.38 B | $6.96 |
0.00%
|
62.3%
|
United States
|
|
335
|
 Autolus Therapeutics
AUTL
|
$0.37 B | $1.40 |
0.00%
|
-50.2%
|
United Kingdom
|
|
336
|
 Kamada
KMDA
|
$0.36 B | $6.29 |
0.00%
|
53.3%
|
Israel
|
|
337
|
 ORIC Pharmaceuticals
ORIC
|
$0.36 B | $5.04 |
0.00%
|
15.1%
|
United States
|
|
338
|
 Rapport Therapeutics
RAPP
|
$0.35 B | $9.60 |
0.00%
|
-21.0%
|
United States
|
|
339
|
 Benitec Biopharma
BNTC
|
$0.35 B | $13.68 |
0.00%
|
126.7%
|
United States
|
|
340
|
 Altimmune
ALT
|
$0.35 B | $4.53 |
0.00%
|
-6.1%
|
United States
|
|
341
|
 Amylyx Pharmaceuticals
AMLX
|
$0.34 B | $3.88 |
0.00%
|
87.0%
|
United States
|
|
342
|
 Erasca
ERAS
|
$0.34 B | $1.19 |
0.00%
|
-10.9%
|
United States
|
|
343
|
 Medios AG
ILM1.DE
|
$0.34 B | $13.13 |
0.00%
|
-2.8%
|
Germany
|
|
344
|
 Tectonic Therapeutic
TECX
|
$0.33 B | $17.94 |
0.00%
|
137.5%
|
United States
|
|
345
|
 Phathom Pharmaceuticals
PHAT
|
$0.33 B | $4.77 |
0.00%
|
-44.8%
|
United States
|
|
346
|
 REGENXBIO
RGNX
|
$0.33 B | $6.55 |
0.00%
|
-53.7%
|
United States
|
|
347
|
 Inventiva
IVA
|
$0.33 B | $3.40 |
0.00%
|
-28.6%
|
France
|
|
348
|
 Mereo BioPharma Group
MREO
|
$0.32 B | $2.00 |
0.00%
|
45.7%
|
United Kingdom
|
|
349
|
 Allogene Therapeutics
ALLO
|
$0.32 B | $1.46 |
0.00%
|
-57.8%
|
United States
|
|
350
|
 Cartesian Therapeutics
RNAC
|
$0.31 B | $11.97 |
0.00%
|
0.05%
|
United States
|
|
351
|
 Rigel Pharmaceuticals
RIGL
|
$0.30 B | $17.04 |
0.00%
|
93.3%
|
United States
|
|
352
|
 Idorsia
IDIA.SW
|
$0.30 B | $1.35 |
0.00%
|
-55.1%
|
Switzerland
|
|
353
|
 Alimera Sciences
ALIM
|
$0.30 B | $5.54 |
0.00%
|
56.1%
|
United States
|
|
354
|
 DocMorris
DOCM.SW
|
$0.30 B | $25.31 |
0.00%
|
-79.9%
|
Switzerland
|
|
355
|
 Entrada Therapeutics
TRDA
|
$0.30 B | $7.87 |
0.00%
|
5.2%
|
United States
|
|
356
|
 Heron Therapeutics
HRTX
|
$0.29 B | $1.92 |
0.00%
|
-40.1%
|
United States
|
|
357
|
 Olema Pharmaceuticals
OLMA
|
$0.29 B | $4.21 |
0.00%
|
-51.8%
|
United States
|
|
358
|
 Arcturus Therapeutics
ARCT
|
$0.29 B | $10.57 |
0.00%
|
-41.7%
|
United States
|
|
359
|
 MaxCyte
MXCT
|
$0.28 B | $2.65 |
0.00%
|
10.7%
|
United States
|
|
360
|
 Aura Biosciences
AURA
|
$0.28 B | $5.57 |
0.00%
|
10.4%
|
United States
|
|
361
|
 Alumis
ALMS
|
$0.28 B | $5.11 |
0.00%
|
-63.8%
|
United States
|
|
362
|
 Atai Life Sciences
ATAI
|
$0.28 B | $1.39 |
0.00%
|
16.2%
|
Germany
|
|
363
|
 Monte Rosa Therapeutics
GLUE
|
$0.27 B | $4.43 |
0.00%
|
11.2%
|
United States
|
|
364
|
 Shinpoong Pharm
019170.KS
|
$0.27 B | $5.49 |
0.00%
|
-29.4%
|
South Korea
|
|
365
|
 Euroapi
EAPI.PA
|
$0.27 B | $2.83 |
0.00%
|
15.9%
|
France
|
|
366
|
 aTyr Pharma
ATYR
|
$0.27 B | $2.99 |
0.00%
|
137.1%
|
United States
|
|
367
|
 Taysha Gene Therapies
TSHA
|
$0.26 B | $1.27 |
0.00%
|
-23.7%
|
United States
|
|
368
|
 2seventy bio
TSVT
|
$0.26 B | $4.97 |
0.00%
|
-51.6%
|
United States
|
|
369
|
 Indoco Remedies
INDOCO.NS
|
$0.26 B | $2.77 |
0.00%
|
-1.7%
|
India
|
|
370
|
 Vanda Pharmaceuticals
VNDA
|
$0.25 B | $4.37 |
0.00%
|
-11.8%
|
United States
|
|
371
|
 Aquestive Therapeutics
AQST
|
$0.25 B | $2.57 |
0.00%
|
-23.7%
|
United States
|
|
372
|
 Emergent BioSolutions
EBS
|
$0.25 B | $4.63 |
0.00%
|
432.1%
|
United States
|
|
373
|
 XOMA
XOMA
|
$0.25 B | $20.80 |
0.00%
|
8.6%
|
United States
|
|
374
|
 Verastem Oncology
VSTM
|
$0.25 B | $4.81 |
0.00%
|
-47.4%
|
United States
|
|
375
|
 Y-mAbs Therapeutics
YMAB
|
$0.24 B | $5.35 |
0.00%
|
-59.3%
|
United States
|
|
376
|
 Atea Pharmaceuticals
AVIR
|
$0.24 B | $2.82 |
0.00%
|
-18.1%
|
United States
|
|
377
|
 Abeona Therapeutics
ABEO
|
$0.24 B | $4.92 |
0.00%
|
-26.6%
|
United States
|
|
378
|
 Compass Therapeutics
CMPX
|
$0.24 B | $1.70 |
0.00%
|
154.9%
|
United States
|
|
379
|
 Monopar Therapeutics
MNPR
|
$0.23 B | $38.36 |
0.00%
|
1484.4%
|
United States
|
|
380
|
 Lifecore Biomedical
LFCR
|
$0.23 B | $6.25 |
0.00%
|
-10.1%
|
United States
|
|
381
|
 Third Harmonic Bio
THRD
|
$0.23 B | $5.12 |
0.00%
|
-58.8%
|
United States
|
|
382
|
 OmniAb
OABI
|
$0.23 B | $1.89 |
0.00%
|
-25.7%
|
United States
|
|
383
|
 Immutep
IMMP
|
$0.23 B | $1.51 |
0.00%
|
-13.3%
|
Australia
|
|
384
|
 iTeos Therapeutics
ITOS
|
$0.23 B | $5.93 |
0.00%
|
-32.8%
|
United States
|
|
385
|
 ACELYRIN
SLRN
|
$0.22 B | $2.23 |
0.00%
|
-62.4%
|
United States
|
|
386
|
 Nuvectis Pharma
NVCT
|
$0.22 B | $9.53 |
0.00%
|
-6.4%
|
United States
|
|
387
|
 Corvus Pharmaceuticals
CRVS
|
$0.22 B | $3.24 |
0.00%
|
269.9%
|
United States
|
|
388
|
 Bastide Le Confort Médical SA
BLC.PA
|
$0.22 B | $29.67 |
0.00%
|
55.9%
|
France
|
|
389
|
 Oriola Oyj
OKDAV.HE
|
$0.21 B | $1.15 |
0.00%
|
-13.1%
|
Finland
|
|
390
|
 CARGO Therapeutics
CRGX
|
$0.21 B | $4.55 |
0.00%
|
-82.5%
|
United States
|
|
391
|
 Terns Pharmaceuticals
TERN
|
$0.21 B | $2.40 |
0.00%
|
-1.8%
|
United States
|
|
392
|
 Solid Biosciences
SLDB
|
$0.21 B | $2.70 |
0.00%
|
-65.6%
|
United States
|
|
393
|
 Protalix BioTherapeutics
PLX
|
$0.20 B | $2.62 |
0.00%
|
133.9%
|
Israel
|
|
394
|
 Ocugen
OCGN
|
$0.20 B | $0.70 |
0.00%
|
-51.4%
|
United States
|
|
395
|
 DBV Technologies S.A.
DBV.PA
|
$0.20 B | $1.49 |
0.00%
|
-35.1%
|
France
|
|
396
|
 enGene
ENGN
|
$0.20 B | $4.00 |
0.00%
|
-62.5%
|
Canada
|
|
397
|
 Amarin Corporation
AMRN
|
$0.20 B | $9.81 |
0.00%
|
-33.7%
|
Ireland
|
|
398
|
 DBV Technologies
DBVT
|
$0.20 B | $7.35 |
0.00%
|
202.9%
|
France
|
|
399
|
 Foghorn Therapeutics
FHTX
|
$0.20 B | $3.57 |
0.00%
|
-8.5%
|
United States
|
|
400
|
 Esperion Therapeutics
ESPR
|
$0.20 B | $1.00 |
0.00%
|
1.1%
|
United States
|